Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C73H131N3O31 |
| Molecular Weight | 1546.8227 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 28 / 28 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@@]5(C[C@H](O)[C@@H](NC(C)=O)[C@@H](O5)[C@H](O)[C@H](O)CO)C(O)=O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)\C=C\CCCCCCCCCCCCC
InChI
InChIKey=QPJBWNIQKHGLAU-IQZHVAEDSA-N
InChI=1S/C73H131N3O31/c1-5-7-9-11-13-15-17-19-20-22-24-26-28-30-32-34-52(87)76-44(45(84)33-31-29-27-25-23-21-18-16-14-12-10-8-6-2)41-98-69-61(94)59(92)63(50(39-80)101-69)103-71-62(95)67(107-73(72(96)97)35-46(85)53(74-42(3)82)66(106-73)55(88)47(86)36-77)64(51(40-81)102-71)104-68-54(75-43(4)83)65(57(90)49(38-79)99-68)105-70-60(93)58(91)56(89)48(37-78)100-70/h31,33,44-51,53-71,77-81,84-86,88-95H,5-30,32,34-41H2,1-4H3,(H,74,82)(H,75,83)(H,76,87)(H,96,97)/b33-31+/t44-,45+,46-,47+,48+,49+,50+,51+,53+,54+,55+,56-,57-,58-,59+,60+,61+,62+,63+,64-,65+,66+,67+,68-,69+,70-,71-,73-/m0/s1
Ganglioside GM1 is a monosialo-glycosphingolipid belonging to the gangliotetrahexosyl series that abundant in neurons of all animal species and plays important roles in many cell physiological processes, including differentiation, memory control, cell signaling, neuronal protection, neuronal recovery, and apoptosis. Ganglioside GM1 in neurons helps to transfer information from the exterior to the interior of the cell, through specific recognition and binding of biologically active molecules (membrane receptors and ion channels), and has specific functions in nerve conduction and/or synaptic transmission. The mechanisms underlying the effects of Ganglioside GM1 remain unclear in many cases, but it appears that these effects are often due to specific interactions between Ganglioside GM1 and proteins involved in signaling processes, within Ganglioside GM1-enriched lipid rafts in the plasma membrane. Ganglioside GM1 is a major component of total ganglioside mixtures from mammalian brains, from which it can be extracted and purified in large amounts. Ganglioside GM1 was widely used in the past as a therapeutic drug for a wide variety of neurological disorders. Further studies have shown that Ganglioside GM1 has immunogenic properties and led to the production of antibodies that promoted peripheral neuropathies such as Guillain–Barré syndrome.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27491214
Curator's Comment: Gangliosides are abundant in neurons of all animal species
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Methylmercury causes neuronal cell death through the suppression of the TrkA pathway: in vitro and in vivo effects of TrkA pathway activators. | 2015-02-01 |
|
| Neurophysiological and immunohistochemical studies of IgG anti-GM1 monoclonal antibody on neuromuscular transmission: effects in rat neuromuscular junctions. | 2014-02 |
|
| Gangliosides inhibit bee venom melittin cytotoxicity but not phospholipase A(2)-induced degranulation in mast cells. | 2011-05-01 |
|
| Inhibitory effect of ganglioside on mastoparan-induced cytotoxicity and degranulation in lipid raft of connective tissue type mast cell. | 2010-04-04 |
|
| Neurochemical changes on oxidative stress in rat hippocampus during acute phase of pilocarpine-induced seizures. | 2010-01 |
|
| The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice. | 2009-03 |
|
| Ganglioside GM1 (porcine) ameliorates paclitaxel-induced neuropathy in rats. | 2009-01 |
|
| Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice. | 2007-09-05 |
|
| Gangliosides trigger inflammatory responses via TLR4 in brain glia. | 2006-05 |
|
| Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barré syndrome. | 2006-05 |
|
| Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy. | 2006-02 |
|
| Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides. | 2005-06-01 |
|
| GM1 enhances dopaminergic markers in the brain of aged rats. | 2003-10 |
|
| Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | 2002-03 |
|
| Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | 2001-02-15 |
|
| Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome? | 2000-08 |
|
| Human monoclonal immunoglobulin M antibodies to ganglioside GM1 show diverse cross-reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barré syndrome. | 1999-07 |
|
| Effects of monosialoganglioside GM1 on scopolamine-induced amnesia. | 1998-06-19 |
|
| Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. | 1994-11 |
|
| GM1 ganglioside attenuates the behavioral deficits but not the granule cell damage produced by intradentate colchicine. | 1989-01-23 |
|
| Further evidence that carbohydrates are the immunodeterminant structures of blood group M and N specificities. | 1981 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000139313
Created by
admin on Mon Mar 31 21:44:26 GMT 2025 , Edited by admin on Mon Mar 31 21:44:26 GMT 2025
|
PRIMARY | |||
|
562413257Z
Created by
admin on Mon Mar 31 21:44:26 GMT 2025 , Edited by admin on Mon Mar 31 21:44:26 GMT 2025
|
PRIMARY | |||
|
61048
Created by
admin on Mon Mar 31 21:44:26 GMT 2025 , Edited by admin on Mon Mar 31 21:44:26 GMT 2025
|
PRIMARY | |||
|
Ganglioside GM1
Created by
admin on Mon Mar 31 21:44:26 GMT 2025 , Edited by admin on Mon Mar 31 21:44:26 GMT 2025
|
PRIMARY | |||
|
m5664
Created by
admin on Mon Mar 31 21:44:26 GMT 2025 , Edited by admin on Mon Mar 31 21:44:26 GMT 2025
|
PRIMARY | Merck Index | ||
|
116950-37-9
Created by
admin on Mon Mar 31 21:44:26 GMT 2025 , Edited by admin on Mon Mar 31 21:44:26 GMT 2025
|
PRIMARY | |||
|
9963963
Created by
admin on Mon Mar 31 21:44:26 GMT 2025 , Edited by admin on Mon Mar 31 21:44:26 GMT 2025
|
PRIMARY | |||
|
SUB87146
Created by
admin on Mon Mar 31 21:44:26 GMT 2025 , Edited by admin on Mon Mar 31 21:44:26 GMT 2025
|
PRIMARY |
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD